You are here

Article info

Article menu

Download PDFPDF

Commentary
Utilization of exosome-based therapies to augment anti-PD-1/PD-L1 therapies

Authors

  • John S. Wang McGaw Medicine Center - Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Samer Yassin McGaw Medicine Center - Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Adam Y. Lin Division of Hematology Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USARobert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Adam Y. Lin; adam.lin{at}northwestern.edu
View Full Text

Citation

Wang JS, Yassin S, Lin AY
Utilization of exosome-based therapies to augment anti-PD-1/PD-L1 therapies
Journal for ImmunoTherapy of Cancer 2025;13:e010603. doi: 10.1136/jitc-2024-010603

Publication history

  • Accepted April 10, 2025
  • First published April 24, 2025.
Online issue publication 
April 24, 2025

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.